Dr. Xianfu Sun 孙献甫
Chief Physician
Department of Breast Surgery, Henan Cancer Hospital, Zhengzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of breast cancer and benign breast diseases, with a focus on comprehensive surgical management of early-stage breast cancer, including modified radical mastectomy, breast-conserving surgery, and immediate or delayed reconstruction.
Dr. Sun is a Chief Physician and medical doctorate holder at Henan Cancer Hospital. A master's supervisor at Zhengzhou University, Dr. Sun was a visiting scholar at Augusta Hospital, University of Duisburg-Essen, and was named a 2025 Henan Provincial Chief Science Popularization Expert.
Professional roles
- Standing Committee Member, International Medical Exchange Branch, China Anti-Cancer Association
- Member, Tumor Heterogeneity and Individualized Treatment Committee, China Anti-Cancer Association
- Standing Committee Member, Young Experts Committee, Chinese Society of Clinical Oncology (CSCO)
- Vice Chair, Oncology Branch, Henan Medical Association
Name order: in Chinese the family name comes first (Sun Xianfu). Papers usually list the name as Xianfu Sun or Sun X.
Selected publications
38 papers on PubMed matched by name and affiliation; 12 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Affect Disord, 2026 (senior author): A head-to-head comparison of gray matter morphological differences between early-onset and middle-to-late-onset depression in a large-scale multi-site cohort. PubMed 41577042
- Front Oncol, 2025 (senior author): Sentinel lymph node biopsy omission in early-stage breast cancer: current evidence and clinical practice. PubMed 40612354
- Sci Rep, 2025 (senior author): Coactivation patterns reveal the abnormality of dynamic state transitions between different psychiatric disorders. PubMed 40169646
- J Cancer, 2025 (senior author): LINC00899 suppresses the progression of triple-negative breast cancer via the miRNA-425/PTEN axis and is a biomarker for neoadjuvant chemotherapy efficacy. PubMed 39991583
- Cereb Cortex, 2024 (senior author): Resolving heterogeneity in schizophrenia, bipolar I disorder, and attention-deficit/hyperactivity disorder through individualized structural covariance network analysis. PubMed 38142281
- Sci Rep, 2023 (senior author): Optimal surgical procedure for treating early-stage adenoid cystic carcinoma of the breast. PubMed 37353590
- Gland Surg, 2021 (first author): Establishing a prediction model of axillary nodal burden based on the combination of CT and ultrasound findings and the clinicopathological features in patients with early-stage breast cancer. PubMed 33708557
- Drug Deliv Transl Res, 2021 (first author): Simultaneous delivery of anti-miRNA and docetaxel with supramolecular self-assembled "chitosome" for improving chemosensitivity of triple negative breast cancer cells. PubMed 32394334
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion